Your shopping cart is empty!
Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
Catalog: | HY-14267 |
Brand: | MCE |
CAS: | 473921-12-9 |
MDL | MFCD16619314 |
---|---|
Molecular Weight | 310.35 |
Molecular Formula | C17H18N4O2 |
SMILES | CCC1=NN(CCO)C(CC)=C1OC2=CC(C#N)=CC(C#N)=C2 |
Lersivirine (UK-453061) is potent and selective non-nucleoside reverse transcription inhibitor (NNRTI; IC 50 =119 nM) with excellent efficacy against NNRTI-resistant viruses. Lersivirine exhibits potent antiretroviral activity against wild-type HIV virus and clinically relevant NNRTI-resistant strains [1] .
IC50: 119 nM (NNRT) [1]
Lersivirine demonstrates excellent activity against large panels of wild type and drug-resistant HIV consistent with the encouraging profile demonstrated against the isolated RT enzymes [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Lersivirine (oral gavage; 0, 150, 350, and 500 mg/kg; once daily; gestation days 6 to 17, followed by cesarean section on gestation day 18. ) allows induction of hepatic metabolizing enzymes at the first 2 days at 250 mg/kg, after which the dose is increased to 500 mg/kg/day in Mated Crl:CD1(ICR) mice. Lersivirine leads to skeletal variations which related to delayed development and decreased fetal ossifications
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
NCT Number | Sponsor | Condition | Start Date | Phase |
---|---|---|---|---|
NCT01254656 | Pfizer|ViiV Healthcare |
HIV-1
|
February 2011 | Phase 2 |
NCT01220232 | Pfizer|ViiV Healthcare |
Healthy Volunteers
|
November 2010 | Phase 1 |
NCT01099748 | Pfizer |
Healthy Volunteers
|
May 2010 | Phase 1 |
NCT01050751 | Pfizer |
Healthy Volunteers
|
February 2010 | Phase 1 |
NCT01603485 | Pfizer|ViiV Healthcare |
Healthy Volunteer
|
June 2012 | Phase 1 |
NCT00925535 | Pfizer |
Healthy Volunteers
|
May 2010 | Phase 1 |
NCT01230385 | Pfizer|ViiV Healthcare |
Healthy Volunteers
|
October 2010 | Phase 1 |
NCT00936871 | Pfizer |
Healthy Volunteers
|
January 2010 | Phase 1 |
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : 50 mg/mL ( 161.11 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 3.2222 mL | 16.1108 mL | 32.2217 mL |
5 mM | 0.6444 mL | 3.2222 mL | 6.4443 mL |
10 mM | 0.3222 mL | 1.6111 mL | 3.2222 mL |
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.